CN202297430U - Plasma protein ultrafiltration membrane device - Google Patents

Plasma protein ultrafiltration membrane device Download PDF

Info

Publication number
CN202297430U
CN202297430U CN2011203704516U CN201120370451U CN202297430U CN 202297430 U CN202297430 U CN 202297430U CN 2011203704516 U CN2011203704516 U CN 2011203704516U CN 201120370451 U CN201120370451 U CN 201120370451U CN 202297430 U CN202297430 U CN 202297430U
Authority
CN
China
Prior art keywords
pipeline
ultrafiltration membrane
tank
communicated
membrane device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2011203704516U
Other languages
Chinese (zh)
Inventor
陈传云
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEFEI XINDA MEMBRAE TECHNOLOGY Co Ltd
Original Assignee
HEFEI XINDA MEMBRAE TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEFEI XINDA MEMBRAE TECHNOLOGY Co Ltd filed Critical HEFEI XINDA MEMBRAE TECHNOLOGY Co Ltd
Priority to CN2011203704516U priority Critical patent/CN202297430U/en
Application granted granted Critical
Publication of CN202297430U publication Critical patent/CN202297430U/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

The utility model discloses a plasma protein ultrafiltration membrane device, comprising a pretreating system, a circulating tank, a preprocessing system and an ultrafiltration membrane system which are communicated mutually through a pipeline, wherein a buffer tank is arranged in the preprocessing system; a cleaning tank is arranged in the ultrafiltration membrane system; a feed port of the cleaning tank is communicated to the preprocessing system through a pipeline; a pressure gage, an ultrafilter, a pressure transmitter, a flowmeter, a temperature sensor and a shut-off valve are arranged in the pipeline; a discharge hole of the ultrafiltration membrane system is communicated to a feed port of a product tank through a pipeline; and an adjusting valve is arranged in the pipeline. The utility model provides the improved and convenient plasma protein ultrafiltration membrane device capable of being used safely and efficiently for a long time, and ultrafiltration membrane equipment with characteristics of practicability, safety, reliability, convenience in operation and the like can be obtained within limited time, so that the manufacturing cost is decreased, and the environmental pressure is reduced.

Description

A kind of plasma proteins ultra-filtration membrane device
Technical field:
The utility model belongs to ultra-filtration membrane and concentrates the material process field, relates in particular to optimize traditional membrane plasmapheresis treatment process and improve the end-use performance of film and the plasma proteins ultra-filtration membrane device in work-ing life.
Background technology:
Extract in the industrial production of concentration at plasma proteins at present; Ultra-filtration membrane equipment is widely used; But in the actual production, but, influence uptime, usefulness and the life-span of ultra-filtration membrane because blood plasma solidifies this specific factor easily; And then influence in time the dust drying and the power consumption of plasma proteins, increased the cost of manufacture and the environmental stress of SDPP.
Therefore, be necessary to transform existing plasma proteins membrane treatment process, design a kind of end-use performance that can in finite time, improve membrane-concentrated blood plasma, prolong the film film treatment facility in work-ing life.
The utility model content:
The purpose of the utility model is in order to remedy the deficiency of prior art; Provide a kind of have improved can long-term safety, high-effect use and plasma proteins ultra-filtration membrane device easily; Solved because blood plasma solidifies this specific factor easily; Influence uptime, usefulness and the life-span of ultra-filtration membrane, and then influence in time the dust drying and the power consumption of plasma proteins, increased the problem such as cost of manufacture and environmental stress of SDPP.
The utility model is realized through following technical scheme:
A kind of plasma proteins ultra-filtration membrane device; Include the preprocessing system, circulation tank, pretreatment system and the ultrafiltration membrane system that are interconnected through pipeline; It is characterized in that: be provided with surge tank in the said pretreatment system; Be provided with purge tank in the said ultrafiltration membrane system, the opening for feed of said purge tank is communicated in pretreatment system through pipeline, and be provided with tensimeter in the pipeline, accurate filter, pressure unit, under meter, TP and stopping valve; The discharge port of said ultrafiltration membrane system is communicated in the opening for feed of product jar through pipeline, and is provided with variable valve in the pipeline.Described plasma proteins ultra-filtration membrane device, it is characterized in that: described accurate filter includes two set filters.
Its principle is: the ultra-filtration membrane equipment work process of the utility model is following; Plasma proteins gets into circulation tank through preprocessing system earlier; Get into the ultrafiltration membrane treatment systemic circulation through pretreatment system again, utilize the stopping valve of dope end in the ultrafiltration membrane system to come the pressure of regulation system, thereby change the treatment capacity of system; Through regulating variable valve, select whether to carry out continuous tupe and the speed of response of product under tupe continuously; The temperature of equipment, pressure and flow come to show respectively through TP, pressure unit, tensimeter and under meter respectively.
The effect of preprocessing system: the blood plasma to just collecting from the blood sampling point carries out filtration treatment, and the blood plasma that removes dirty, foreign material and solidified avoids stopping up the pipeline of outlet of circulation cold-storage jar and next stage treatment system; The effect of pretreatment system: the blood plasma of collecting in the circulation tank advances the processing before the ultrafiltration membrane system; Accurate filter has increased by a set filter, and system moves continuously thereby the production process assurance has been simplified in this improvement, and the film of having avoided frequent shutdown to cause pollutes even stops up, and is practical, convenient, for a large amount of quality time are won in blood plasma production; Surge tank is used for reclaiming the product water of ultrafiltration blood plasma, can be used to clean pretreatment system and ultrafiltration membrane system, practices thrift the mass production water and has reduced the sewage emissions amount; Variable valve and this technology of associated pipe of increasing have shortened time of plasma extraction, have avoided blood plasma and have solidified this unfavorable factor easily, and then avoided the dirt of equipment stifled, make the actual production pattern more flexible,
The utility model has the advantages that:
The utility model be have improved can long-term safety, high-effect and easy-to-use plasma proteins ultra-filtration membrane device; Can in the limited time, obtain the ultra-filtration membrane equipment of many characteristics such as having practicality, safe, reliable, easy to operate; Reduce cost of manufacture, reduced environmental stress.
Description of drawings:
Fig. 1 is the utility model structural representation.
Among the figure: 1: preprocessing system, 2: pretreatment system, 3: ultrafiltration membrane system, 4: circulation tank, 5: surge tank, 6: purge tank, 7: product jar, 8: accurate filter, 9: variable valve, 10: stopping valve, 11: under meter, 12: tensimeter, 13: pressure unit, 14: TP
Embodiment:
Referring to accompanying drawing; A kind of plasma proteins ultra-filtration membrane device; Include the preprocessing system 1, circulation tank 4, pretreatment system 2 and the ultrafiltration membrane system 3 that are interconnected through pipeline, be provided with surge tank 5 in the pretreatment system 2, be provided with purge tank 6 in the ultrafiltration membrane system 3; The bottom feed mouth of purge tank 6 is communicated in pretreatment system 2 through pipeline; And be provided with tensimeter 12, accurate filter 8, pressure unit 13, under meter 11, TP 14 and stopping valve 10 in the pipeline, the discharge port of ultrafiltration membrane system is communicated in the opening for feed of product jar 7 through pipeline, and is provided with variable valve 9 in the pipeline; Described accurate filter 8 includes two set filters.

Claims (2)

1. plasma proteins ultra-filtration membrane device; Include the preprocessing system, circulation tank, pretreatment system and the ultrafiltration membrane system that are interconnected through pipeline; It is characterized in that: be provided with surge tank in the said pretreatment system; Be provided with purge tank in the said ultrafiltration membrane system, the opening for feed of said purge tank is communicated in pretreatment system through pipeline, and be provided with tensimeter in the pipeline, accurate filter, pressure unit, under meter, TP and stopping valve; The discharge port of said ultrafiltration membrane system is communicated in the opening for feed of product jar through pipeline, and is provided with variable valve in the pipeline.
2. plasma proteins ultra-filtration membrane device according to claim 1, it is characterized in that: described accurate filter includes two set filters.
CN2011203704516U 2011-09-30 2011-09-30 Plasma protein ultrafiltration membrane device Expired - Fee Related CN202297430U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2011203704516U CN202297430U (en) 2011-09-30 2011-09-30 Plasma protein ultrafiltration membrane device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2011203704516U CN202297430U (en) 2011-09-30 2011-09-30 Plasma protein ultrafiltration membrane device

Publications (1)

Publication Number Publication Date
CN202297430U true CN202297430U (en) 2012-07-04

Family

ID=46366367

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2011203704516U Expired - Fee Related CN202297430U (en) 2011-09-30 2011-09-30 Plasma protein ultrafiltration membrane device

Country Status (1)

Country Link
CN (1) CN202297430U (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103463979A (en) * 2013-09-18 2013-12-25 浙江索纳克生物科技有限公司 Environment-friendly and high-efficient blood plasma concentration device
CN103933862A (en) * 2014-04-24 2014-07-23 合肥信达膜科技有限公司 Membrane method extraction system and membrane method extraction process for alanine production

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103463979A (en) * 2013-09-18 2013-12-25 浙江索纳克生物科技有限公司 Environment-friendly and high-efficient blood plasma concentration device
CN103933862A (en) * 2014-04-24 2014-07-23 合肥信达膜科技有限公司 Membrane method extraction system and membrane method extraction process for alanine production

Similar Documents

Publication Publication Date Title
CN204911543U (en) Hydrogen cation exchange resin's for conductivity measurement regenerating unit
CN202297430U (en) Plasma protein ultrafiltration membrane device
CN203764143U (en) Device for testing reverse osmosis membrane elements and nanofiltration membrane elements in batches
CN203820511U (en) Special movable cleaning device for EDI modules
CN201728062U (en) Automatic cleaning continuous cross-flow ultrafiltration device
CN203461912U (en) Purification treatment device for inner cooling water of converter valves
CN203648395U (en) Automatic ultra-filtration system
CN203264423U (en) Filtering alarm control device
CN104084047A (en) Glycyrrhiza extracting solution clarification and concentration membrane system
CN105036245B (en) A kind of middle temperature biogas slurry waste water tubular type ultrafiltration membrane system processing and reuse technology
CN208505956U (en) A kind of device of on-line continuous detection catalyst reaction liquid pH value
CN202876514U (en) Full-automatic liquid material filter
CN202506317U (en) Reverse osmosis membrane pulse filter
CN206590998U (en) A kind of centralized direct drinking water purification device
CN206424794U (en) Internal circulating membrane system
CN206109366U (en) Novel fruit wine clarification filtration system
CN205109418U (en) Positive osmotic membrane component capability test device
CN104944618A (en) Reverse osmosis membrance water purifier
CN204588769U (en) A kind of multifunctional membrane biological sewage treatment facility
CN204981266U (en) Ultrafiltration device with adjust running water pressure function
CN103657415B (en) The hyperfiltration process of a kind of automatic ultrafiltration system under linear transmembrane pressure
CN204981416U (en) EDI valves device
CN103691322A (en) Automatic ultrafiltration system and method for implementing ultrafiltration under constant transmembrane pressure by utilizing same
CN203529958U (en) Sewage purifying device
CN203342787U (en) Liquid level control system of blowdown collection tank

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20120704

Termination date: 20140930

EXPY Termination of patent right or utility model